Clarisoft customer receives $20M investment

On April 7th, 2015, Livongo Health announced that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ Ventures and previous investor General Catalyst. The funding will enable the company to further develop its chronic disease management ecosystem and accelerate the adoption of the company’s digital diabetes management program, Livongo for Diabetes™, among self-insured employers, healthcare providers and payers.

Our customer’s success of digital diabetes management program = Our Success

Livongo Health is among a select group of companies receiving funding from KPCB. These include Google, Twitter, Amazon, and EA Electronic Arts. We like to think Clarisoft Technologies played a part in Livongo Heath joining this exclusive company.

This is another recent example of the success and bright future of the companies we work with. At Clarisoft Technologies our number one goal is to help our partners succeed in growing their business. The key word is partner! We are interested in partner relationship and not customer relationships.

Allow us to help you with your software development projects. We have expertise in a wide range of technologies. Our offshore staff of over 40 developers combined with our US based management make our hybrid approach successful to many companies like Livongo Health.

ClarisoftTechnologies:
Related Post